Lifestyle Medication to Manage Type 2 Diabetes and Its Impact on Biochemical Parameters
DOI:
https://doi.org/10.71005/5g0b3292Keywords:
diabetes, life style, exerciseAbstract
Insulin resistance and high blood sugar are hallmarks of type 2 diabetes mellitus, a common chronic illness that has a substantial influence on world health. In order to avoid problems like cardiovascular disease and neuropathy, effective care is essential. Pharmacological therapies are frequently used in traditional diabetes treatment. However, lifestyle improvements, including dietary adjustments, exercise, and stress reduction, have become essential elements of diabetic care. In order to improve glycemic control in individuals with type 2 diabetes, this study compares the efficacy of lifestyle medicine and standard therapy. In Punjab, Pakistan, a randomized controlled trial (RCT) was carried out in the cities of Kahuta and Faisalabad. One hundred volunteers, all between the ages of 35 and 50, who had been diagnosed as having type 2 diabetes and had HbA1c levels ≥6.5%, participated in the study. Participants were randomized to either Group B, which received normal medical care, or Group A, which received lifestyle interventions. Dietary changes, exercise routines, stress management strategies, and adherence counseling were the main focuses of the lifestyle intervention. To improve glycemic control, the seeds of chia and melon, especially bitter melon, were important dietary components. SPSS version 26 was used to analyze the data. Both groups showed significant improvements, according to within-group analysis (p-value <0.001). When compared to standard medical care, between-group analysis demonstrated the effectiveness of lifestyle interventions in controlling a number of health indices in diabetes patients, especially fasting blood glucose, cholesterol, CRP, BMI, or waist measurement (p-value <0.001). However, several variables such as blood pressure did not exhibit significant changes (p-value >0.05). The study concluded that intensive lifestyle changes can lead to meaningful improvements in metabolic health outcomes for individuals with type 2 diabetes, aligning with broader research advocating for such approaches as foundational components of diabetes care strategies
References
Abdul Basith Khan, M., M.J. Hashim, J.K. King, R.D. Govender, H. Mustafa and J. Al-Kaabi. (2020). Epidemiology of type 2 diabetes—global burden of disease and forecasted trends. Journal of epidemiology and global health, 10(1), 107-111.
Adil, Y. and K.H. Ismail. (2024). The Effect of Lifestyle Intervention on Glycemic Control in Type 2 Diabetic Patients. Bahrain Medical Bulletin, 46(1).
Adnan, M. and M. Aasim. (2020). Prevalence of type 2 diabetes mellitus in adult population of Pakistan: a meta-analysis of prospective cross-sectional surveys. Annals of global health, 86(1), 7.
Ahmad, E., S. Lim, R. Lamptey, D.R. Webb and M.J. Davies. (2022). Type 2 diabetes. The Lancet, 400(10365), 1803-1820.
Al-Mukhtar, S.B., N.N. Fadhil and B.E. Hanna. (2012). General and gender characteristics of type 2 diabetes mellitus among the younger and older age groups. Oman Medical Journal, 27(5), 375.
Almeida, V.D.C.F.D., M.L. Zanetti, P.C.D. Almeida and M.M.C. Damasceno. (2011). Occupation and risk factors for type 2 diabetes: a study with health workers. Revista Latino-Americana de Enfermagem, 19, 476-484.
Awasthi, A., C.R. Rao, D. Hegde and K. RAO. (2017). Association between type 2 diabetes mellitus and anthropometric measurements–a case control study in South India. Journal of preventive medicine and hygiene, 58(1), E56.
Boye, K.S., M.J. Lage, S. Shinde, V. Thieu and J.P. Bae. (2021). Trends in HbA1c and body mass index among individuals with type 2 diabetes: evidence from a US database 2012–2019. Diabetes Therapy, 12(7), 2077-2087.
Campbell, S.A., D.P. Golec, M. Hubert, J. Johnson, N. Salamon, A. Barr, P.E. MacDonald, K. Philippaert and P.E. Light. (2020). Human islets contain a subpopulation of glucagon-like peptide-1 secreting α cells that is increased in type 2 diabetes. Molecular metabolism, 39, 101014.
Campione, J.R., N.D. Ritchie, H.A. Fishbein, R.E. Mardon, M.C. Johnson Jr, W. Pace, R.J. Birch, E.L. Seeholzer, X. Zhang and K. Proia. (2022). Use and impact of type 2 diabetes prevention interventions. American journal of preventive medicine, 63(4), 603-610.
Coppola, A., L. Sasso, A. Bagnasco, A. Giustina and C. Gazzaruso. (2016). The role of patient education in the prevention and management of type 2 diabetes: an overview. Endocrine, 53, 18-27.
Costanzo, M.C., M. von Grotthuss, J. Massung, D. Jang, L. Caulkins, R. Koesterer, C. Gilbert, R.P. Welch, P. Kudtarkar and Q. Hoang. (2023). The Type 2 Diabetes Knowledge Portal: An open access genetic resource dedicated to type 2 diabetes and related traits. Cell metabolism, 35(4), 695-710. e696.
Dagliati, A., L. Sacchi, M. Bucalo, D. Segagni, K. Zarkogianni, A.M. Millana, J. Cancela, F. Sambo, G. Fico and M.T.M. Barreira. (2014). A data gathering framework to collect type 2 diabetes patients data. IEEE-EMBS International Conference on Biomedical and Health Informatics (BHI),
Diawara, A., D.M. Coulibaly, T.Y.A. Hussain, C. Cisse, J. Li, M. Wele, M. Diakite, K. Traore, S.O. Doumbia and J.G. Shaffer. (2023). Type 2 diabetes prevalence, awareness, and risk factors in rural Mali: a cross-sectional study. Scientific Reports, 13(1), 3718.
Dingena, C.F.B.A. (2023). Lifestyle Mediators of Dysglycaemia in Pregnancy: Towards Novel Strategies for Diabetes Management in Pregnancy University of Leeds].
Durlach, V., B. Verges, A. Al-Salameh, T. Bahougne, F. Benzerouk, I. Berlin, C. Clair, J. Mansourati, A. Rouland and D. Thomas. (2022). Smoking and diabetes interplay: a comprehensive review and joint statement. Diabetes & metabolism, 48(6), 101370.
Ellulu, M.S. and H. Samouda. (2022). Clinical and biological risk factors associated with inflammation in patients with type 2 diabetes mellitus. BMC Endocrine Disorders, 22(1), 16.
Hazuda, H.P., Q. Pan, H. Florez, J.A. Luchsinger, J.P. Crandall, E.M. Venditti, S.H. Golden, A.M. Kriska and G.A. Bray. (2021). Association of intensive lifestyle and metformin interventions with frailty in the diabetes prevention program outcomes study. The Journals of Gerontology: Series A, 76(5), 929-936.
Hejazi, K., G.R. Mohammad Rahimi and S.K. Rosenkranz. (2023). Effects of exercise training on inflammatory and cardiometabolic risk biomarkers in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Biological Research For Nursing, 25(2), 250-266.
Hu, Y., X. Zhang, Y. Ma, C. Yuan, M. Wang, K. Wu, F.K. Tabung, D. Tobias, F.B. Hu and E. Giovannucci. (2021). Incident type 2 diabetes duration and cancer risk: a prospective study in two US cohorts. JNCI: Journal of the National Cancer Institute, 113(4), 381-389.
Hukportie, D.N., F.R. Li, R. Zhou, J.Z. Zheng, X.X. Wu and X.B. Wu. (2021). Anthropometric measures and incident diabetic nephropathy in participants with type 2 diabetes mellitus. Frontiers in endocrinology, 12, 706845.
Hussein, W.N., Z.M. Mohammed and A.N. Mohammed. (2022). Identifying risk factors associated with type 2 diabetes based on data analysis. Measurement: Sensors, 24, 100543.
Jarrar, M.T., M.A.H. Abusalah, W. Albaker, M. Al-Bsheish, A. Alsyouf, K. Al-Mugheed, M.R. Issa and A. Alumran. (2023). Prevalence of type 2 diabetes mellitus in the general population of Saudi Arabia, 2000–2020: A systematic review and meta-analysis of observational studies. Saudi Journal of Medicine & Medical Sciences, 11(1), 1-10.
Johansen, M.Y., C.S. MacDonald, K.B. Hansen, K. Karstoft, R. Christensen, M. Pedersen, L.S. Hansen, M. Zacho, A.S. Wedell-Neergaard and S.T. Nielsen. (2017). Effect of an intensive lifestyle intervention on glycemic control in patients with type 2 diabetes: a randomized clinical trial. Jama, 318(7), 637-646.
Kanaley, J.A., S.R. Colberg, M.H. Corcoran, S.K. Malin, N.R. Rodriguez, C.J. Crespo, J.P. Kirwan and J.R. Zierath. (2022). Exercise/physical activity in individuals with type 2 diabetes: a consensus statement from the American College of Sports Medicine. Medicine and science in sports and exercise, 54(2), 353.
Kumar, S. and V.K. Agarwal. (2022). Correlation of Glycated Haemoglobin (Hb1Ac) and Serum Lipid-Profile in Type 2 Diabetes Patients. Applied sciences, 34(1), 11-17.
Landgraf, W., G. Bigot, S. Hess, O. Asplund, L. Groop, E. Ahlqvist, A. Karajamaki, D.R. Owens, B.M. Frier and G.B. Bolli. (2022). Distribution and characteristics of newly-defined subgroups of type 2 diabetes in randomised clinical trials: Post hoc cluster assignment analysis of over 12,000 study participants. Diabetes Research and Clinical Practice, 190, 110012.
Lawrence, J.M., J. Divers, S. Isom, S. Saydah, G. Imperatore, C. Pihoker, S.M. Marcovina, E.J. Mayer-Davis, R.F. Hamman and L. Dolan. (2021). Trends in prevalence of type 1 and type 2 diabetes in children and adolescents in the US, 2001-2017. Jama, 326(8), 717-727.
Malakar, S., S.K. Singh and K. Usman. (2024). Optimizing Blood Pressure Management in Type 2 Diabetes: A Comparative Investigation of One-Time Versus Periodic Lifestyle Modification Counseling. Cureus, 16(6).
Mathew, T.K. and P. Tadi. (2020). Blood glucose monitoring.
Mehmood, Y., Yousaf, H., Riaz, H., Raza, S. A., Saeed-Ul-Hassan, S., Shafique, M., ... & Khan, Z. M. U. D. Incidence of Tuberculosis in Diabetic Patients. International Journal of Tropical Disease and Health, 24(4), 1-6.
Mehmood, Y., Shahid, H., Ul Huq, U. I., Rafeeq, H., Khalid, H. M. B., Uddin, M. N., & Kazi, M. (2023). Microsponge-Based Gel Loaded with Immunosuppressant as a Simple and Valuable Strategy for Psoriasis Therapy: Determination of Pro-Inflammatory Response through Cytokine IL-2 mRNA Expression. Gels (Basel, Switzerland), 9(11), 871.
Mehmood, Y., Shahid, H., Abbas, M., Farooq, U., Alshehri, S., Alam, P., Shakeel, F., & Ghoneim, M. M. (2023). Developing Nanosuspension Loaded with Azelastine for Potential Nasal Drug Delivery: Determination of Proinflammatory Interleukin IL-4 mRNA Expression and Industrial Scale-Up Strategy. ACS omega, 8(26), 23812–23824.
Mehmood, Y., Shahid, H., Rashid, M. A., Alhamhoom, Y., & Kazi, M. (2022). Developing of SiO2 Nanoshells Loaded with Fluticasone Propionate for Potential Nasal Drug Delivery: Determination of Pro-Inflammatory Cytokines through mRNA Expression. Journal of functional biomaterials, 13(4), 229.
Michalakis, K. and I. Ilias. (2020). SARS-CoV-2 infection and obesity: Common inflammatory and metabolic aspects. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(4), 469-471.
Misra, B.B. and A. Misra. (2020). The chemical exposome of type 2 diabetes mellitus: Opportunities and challenges in the omics era. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(1), 23-38.
Muthukumaraswamy, S.D., A. Forsyth and T. Lumley. (2021). Blinding and expectancy confounds in psychedelic randomized controlled trials. Expert review of clinical pharmacology, 14(9), 1133-1152.
Okonta, H.I., G.A. Ogunbanjo and J.B. Ikombele. (2014). Knowledge, attitude and practice regarding lifestyle modification in type 2 diabetic patients. African Journal of Primary Health Care and Family Medicine, 6(1), 1-6.
Palu, E., F. MacMillan, K.A. McBride, R. Thomson, R. Zarora andd D. Simmons. (2022). Effects of lifestyle interventions on weight amongst Pasifika communities: A systematic review and meta-analysis. The Lancet Regional Health–Western Pacific, 25.
Papakonstantinou, E., C. Oikonomou, G. Nychas and G.D. Dimitriadis. (2022). Effects of diet, lifestyle, chrononutrition and alternative dietary interventions on postprandial glycemia and insulin resistance. Nutrients, 14(4), 823.
Pot, G.K., M.C. Battjes-Fries, O.N. Patijn, N. van der Zijl, H. Pijl and P. Voshol. (2020). Lifestyle medicine for type 2 diabetes: practice-based evidence for long-term efficacy of a multicomponent lifestyle intervention (Reverse Diabetes2 Now). BMJ nutrition, prevention & health, 3(2), 188.
Przezak, A., W. Bielka and A. Pawlik. (2022). Hypertension and type 2 diabetes—the novel treatment possibilities. International journal of molecular sciences, 23(12), 6500.
Radzevičienė, L. and R. Ostrauskas. (2013). Body mass index, waist circumference, waist–hip ratio, waist–height ratio and risk for type 2 diabetes in women: A case–control study. Public health, 127(3), 241-246.
Rahimi, G.R.M., H.A. Yousefabadi, A. Niyazi, N.M. Rahimi and Y. Alikhajeh. (2022). Effects of lifestyle intervention on inflammatory markers and waist circumference in overweight/obese adults with metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials. Biological Research For Nursing, 24(1), 94-105.
Ramirez-Manent, J.I., A.A. Lopez-Gonzalez, E. Martinez-Almoyna Rifa, H. Paublini Oliveira, C. Martorell Sanchez and P. Tarraga Lopez. (2025). Association between sociodemographic variables, healthy habits and stress with insulin resistance risk scales. J. Health. Sci, 40, 107-116.
Saberi‐Karimian, M., A. Mansoori, M.M. Bajgiran, Z.S. Hosseini, A. Kiyoumarsioskouei, E.S. Rad, M.M. Zo, N.Y. Khorasani, M. Poudineh and S. Ghazizadeh. (2023). Data mining approaches for type 2 diabetes mellitus prediction using anthropometric measurements. Journal of Clinical Laboratory Analysis, 37(1), e24798.
Saeed, M., M. Ali, T. Zehra, S.A.H. Zaidi and R. Tariq. (2021). Intermittent fasting: a user-friendly method for type 2 diabetes mellitus. Cureus, 13(11).
Sampson, M., T. Elwell-Sutton, M.O. Bachmann, A. Clark, K.K. Dhatariya, C. Ferns, A. Howe, W.G. John, G. Rayman and L. Swafe. (2018). Discordance in glycemic categories and regression to normality at baseline in 10,000 people in a Type 2 diabetes prevention trial. Scientific Reports, 8(1), 6240.
Seiglie, J., J. Platt, S.J. Cromer, B. Bunda, A.S. Foulkes, I.V. Bassett, J. Hsu, J.B. Meigs, A. Leong and M.S. Putman. (2020). Diabetes as a risk factor for poor early outcomes in patients hospitalized with COVID-19. Diabetes care, 43(12), 2938-2944.
Taheri, S., H. Zaghloul, O. Chagoury, S. Elhadad, S.H. Ahmed, N. El Khatib, R. Abou Amona, K. El Nahas, N. Suleiman and A. Alnaama. (2020). Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial. The lancet Diabetes & endocrinology, 8(6), 477-489.
Taylor, R. (2024). Understanding the cause of type 2 diabetes. The lancet Diabetes & endocrinology.
Taylor, S.I., Z.S. Yazdi and A.L. Beitelshees. (2021). Pharmacological treatment of hyperglycemia in type 2 diabetes. The Journal of clinical investigation, 131(2).
Tinajero, M.G. and V.S. Malik. (2021). An update on the epidemiology of type 2 diabetes: a global perspective. Endocrinology and Metabolism Clinics, 50(3), 337-355.
Tomic, D., J.E. Shaw and D.J. Magliano. (2022). The burden and risks of emerging complications of diabetes mellitus. Nature Reviews Endocrinology, 18(9), 525-539.
Udupa, H., A. Viswanath, P.U. Shenoy, K.J. Antao and R. Das. (2023). Medication Adherence in Elderly Diabetic Patients: A Cross-Sectional Study From Dakshina Kannada, India. Cureus, 15(8).
Wu, K.L., C.P. Shih, J.S. Chan, C.H. Chung, H.C. Lin, C.H. Tsao, F.H. Lin, W.C. Chien and P.J. Hsiao. (2020). Investigation of the relationship between sensorineural hearing loss and associated comorbidities in patients with chronic kidney disease: A nationwide, population-based cohort study. PloS one, 15(9), e0238913.
Yang, W., D. Zhu, S. Gan, X. Dong, J. Su, W. Li, H. Jiang, W. Zhao, M. Yao and W. Song. (2022). Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial. Nature medicine, 28(5), 974-981.
Younis, H.Y., I.A. Thanoon, N.N. Fadhil and M.M. Merkhan. (2022). Effect of zinc as an add-on to metformin therapy on glycemic control, serum insulin, and c-peptide levels and insulin resistance in type 2 diabetes mellitus patient. Research Journal of Pharmacy and Technology, 15(3), 1184-1188.
Yu, R., X. Liu, R. Li and X. Xiao. (2024). Ten‐year clinical characteristics of patients with early‐onset type 2 diabetes: A single‐center experience in China. Journal of Diabetes, 16(1), e13477.